DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG 

10.11.2011 13:25

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Pursuant to sections 21 (1), 24 WpHG ('German Securities Trading Act'), in
conjunction with section 32 (2) InvG ('German Investment Act'), Deutsche
Bank AG, London Branch, Great Britain, on 9th of November 2011 notified us
that the percentage of voting rights of its subsidiary DWS Investment GmbH,
Frankfurt, Germany, in STADA Arzneimittel AG, Bad Vilbel, Germany, crossed
above the threshold of 3 % on 4th of November 2011 and amounts to 3,023 %
(1.782.270 voting rights) as per this date.



10.11.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Germany
Internet:     www.stada.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------